Clinical trials
Terminated Myeloproliferative Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 7 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 10 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 93 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 9 |
| OHSU Knight Cancer Institute | 6 |
| Baylor College of Medicine | 4 |
| City of Hope Medical Center | 4 |
| National Cancer Institute (NCI) | 4 |
| Vanderbilt-Ingram Cancer Center | 4 |
| CTI BioPharma | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| Masonic Cancer Center, University of Minnesota | 3 |
| Mayo Clinic | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 93 |
| Primary Myelofibrosis | 50 |
| Myelodysplastic Syndromes | 49 |
| Leukemia, Myeloid, Acute | 45 |
| Multiple Myeloma | 42 |
| Leukemia | 39 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 38 |
| Lymphoma, Non-Hodgkin | 37 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 35 |
| Leukemia, Myelomonocytic, Chronic | 34 |
Trials
Showing 76 to 93 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.